Kiniksa Share Price

Kiniksa Share Price

NASDAQ: KNSA | Mid Cap | Healthcare
$95.04
-$0.06 (-0.06%) Last updated on 19 Nov, 2026 | 01:28 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Kiniksa Stock Performance

Open
$96.48
Prev. Close
$95.10
Circuit Range
N/A
Day Range
$94.66 - $96.98
Year Range
$37.09 - $99.31
Volume
12,939
Average Traded
$95.27

Kiniksa Share Price Today

As of 19 November 2026, Kiniksa Pharmaceuticals International, plc Class A's share price is $95.04. The stock opened at $96.48, compared to its previous close of $95.10. During today's trading session, Kiniksa Pharmaceuticals International, plc Class A's share price traded between $94.66 and $96.98, with an average price of $95.82. Over the past 52 weeks, the stock has recorded a high of $99.31 and a low of $37.09. In terms of performance, Kiniksa Pharmaceuticals International, plc Class A's share price has risen by 96.40% over the last six months and is up 123.68% on a year-on-year basis.

Kiniksa Share Price Chart

Line chart of the Kiniksa price trend over the selected period. The price fell overall, ranging from 94.66 to 97.08, ending at 95.04.
$94.66$96.98
L
Show Current Price
H

Kiniksa Stock Fundamentals & Key Indicators

Market Cap
$7.05B
PE Ratio (TTM)
68.20
Dividend Yield
0.00%
EPS (TTM)
$1.39
Revenue (TTM)
$677.56B
Return On Equity (TTM)
15.43%
Profit Margin
8.71%
Debt to Equity
0.15
Quarterly Earnings Growth YoY
233.45%

Kiniksa Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$202.13$214.27$243.60$285.97
Net Profit$14.20$22.59$25.43$47.35
Net Profit Margin7.03%10.54%10.44%16.56%
Income ChangeN/A59.08%12.57%86.20%

Kiniksa Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$220.18$270.26$423.24$677.56
Net Profit$183.36$14.08-$43.19$59.01
Net Profit Margin83.28%5.21%-10.20%8.71%
Income ChangeN/A-92.32%-406.75%236.63%

Kiniksa Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets236.46248.75250.03216.61
Current Assets527.18331.8276.3243.06
Total Assets763.63580.55526.32459.67
Non Current Liabilities56.8441.523.8216.46
Current Liabilities139.18100.6263.6747.07
Total Liabilities196.03142.1287.4863.52
Shareholders' Equity567.61438.44438.84396.15

Kiniksa Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating137.9925.6913.35.81
Investing-188.9937.67-29.56-8.08
Financing33.0212.271.52.52

About Kiniksa

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.

Kiniksa Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$93.18
$94.93
+3.13%
Oct 2026
$73.87
$92.05
+23.29%
Sep 2026
$78.93
$74.66
-6.34%
Aug 2026
$73.19
$79.71
+7.14%
Jul 2026
$63.51
$74.40
+16.40%
Jun 2026
$47.66
$63.92
+32.09%
May 2026
$53.38
$48.39
-9.96%
Apr 2026
$48.90
$53.74
+11.29%
Mar 2026
$44.13
$48.29
+8.50%
Feb 2026
$43.84
$44.51
+1.40%
Jan 2026
$41.50
$43.89
+6.58%
Dec 2025
$42.39
$41.18
-3.08%

Kiniksa Share Price FAQs